Papillary renal cell carcinoma

N Mendhiratta, P Muraki, AE Sisk Jr, B Shuch - … Oncology: Seminars and …, 2021 - Elsevier
Kidney cancer is the 13th most common malignancy globally, and the incidence is rising.
Papillary renal cell carcinoma is the second most common subtype, comprising 10-15% of …

[HTML][HTML] Characteristics, aetiology and implications for management of multiple primary renal tumours: a systematic review

H Zhang, A Andreou, R Bhatt, J Whitworth… - European Journal of …, 2024 - nature.com
In a subset of patients with renal tumours, multiple primary lesions may occur. Predisposition
to multiple primary renal tumours (MPRT) is a well-recognised feature of some inherited …

[HTML][HTML] Single-cell RNA-seq identification of the cellular molecular characteristics of sporadic bilateral clear cell renal cell carcinoma

Z Yu, W Lu, C Su, Y Lv, Y Ye, B Guo, D Liu… - Frontiers in …, 2021 - frontiersin.org
Bilateral renal cell carcinoma (RCC) is a rare disease that can be classified as either familial
or sporadic. Studying the cellular molecular characteristics of sporadic bilateral RCC is …

[HTML][HTML] Risk of second primary malignancies in colon cancer patients treated with colectomy

B Zhang, K Guo, X Zheng, L Sun, M Shen… - Frontiers in …, 2020 - frontiersin.org
Background: Second primary malignancy (SPM) attracts a growing attention. However, the
clinical features of colon cancer (CC) survivors with SPMs are not clear and could help …

[HTML][HTML] Differential VHL mutation patterns in bilateral clear cell RCC distinguishes between independent primary tumors and contralateral metastatic disease

CD Vocke, CJ Ricketts, AR Metwalli, PA Pinto… - Urology, 2022 - Elsevier
Objective To evaluate whether bilateral, multifocal clear cell renal cell carcinoma (ccRCC)
patients can be differentiated by VHL mutation analysis into cases that represent either …

Utilization of a Third-party Partnership in Tele-genetic Risk Assessment Program in Genitourinary Oncology

L Lin, E Lu, J Yurasits, J Mercado, M Myers, S Holden… - Urology, 2024 - Elsevier
Objective To meet the increasing demands of genetic risk assessment for genitourinary
cancers due to expanded clinical guidelines, we established an academic/industry …

[HTML][HTML] Second primary cancers after kidney cancers, and kidney cancers as second primary cancers

G Zheng, K Sundquist, J Sundquist, T Chen… - European urology open …, 2021 - Elsevier
Abstract Background Second primary cancers (SPCs) are increasing due to improving
survival in first primary cancers. Previous studies on SPCs in renal cell carcinoma (RCC) …

[HTML][HTML] Adjuvant therapy fails to show survival benefit for patients with spindle cell carcinoma: Evidence from the surveillance, epidemiology, and end results …

T Li, Q Xie, J Li, Z Li, J Xiao, M Liu, J Wang… - Journal of Cancer …, 2021 - journals.lww.com
Background: Spindle cell carcinoma (SpCC) is a rare tumor type with poor prognosis, and
standard treatment modalities are not available yet. However, large-scale studies on this …

[HTML][HTML] Metachronous renal cell carcinoma: an unbeatable leviathan?

A Antonelli, A Veccia, R Autorino - Annals of Translational …, 2019 - ncbi.nlm.nih.gov
Renal cell carcinoma (RCC) is a heterogeneous tumor, even within the same histological
type (1). This feature, combined with non-modifiable (age, sex, race, genetic), and …

[HTML][HTML] Metastasectomy of Sequential Asynchronous Metastatic Renal Cell Carcinoma to the Pancreas, Thyroid, Skin, Contralateral Kidney, and Lung with …

AM Alzahrani, MA Aggamy, AA Joudeh… - The American Journal …, 2021 - ncbi.nlm.nih.gov
Objective: Unusual setting of medical care Background: One-third of renal cell carcinoma
cases present with an initial metastasis to various organs, emphasizing the tumor's …